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Background
●

Placebo response in clinical trials - “improvement in pain due to the
psychological eﬀect of receiving treatment”

●

Drug eﬀect is measured in clinical trials; Drug eﬀect = Drug relief - Placebo
relief

●

High placebo response leads to “clinical trial failure” or a small drug eﬀect
○

EXAMPLE:
■

Drug relief: -5,

■

Placebo relief: -1 vs. -3

■

Drug eﬀect: -4 and -2

Background (cont.)
●

Current research aims to ﬁnd correlates that predict placebo responders

●

Pain variability: previously identiﬁed correlate of placebo response

● Previous research does not account for confounding variables
(pre-intervention pain and natural history of disease)

Research Objectives
Derive the strength of the relationship between baseline pain variability and
relief while controlling for the eﬀects of pre-intervention pain and natural
history between treatment groups.

Methods
●
●

Used data from two clinical trials; both included no treatment (no_tx) and
placebo groups, only one included a drug group (Placebo II)
post ~ pre + group*sd (group is a factor, used for linear contrasts)
○

○

included pre-intervention pain as a covariate to control for pre-intervention pain
isolated eﬀect by group to control for natural history by using linear contrasts
■
■
■

placebo improvement = no_tx + placebo
drug improvement = no_tx + placebo + drug
drug = drug improvement - placebo improvement = (no_tx + placebo + drug) - (no_tx +
placebo) = drug

Methods (cont.)
●

Calculated semipartial correlations using multiple regression model (post ~
pre + group*sd)
○

variance accounted for by ONE variable; reduces confounding eﬀects

rsp = semipartial r
t = t-statistic (of variability)
R2 = model coeﬃcient of determination (global ﬁt of the
model)
df = residual degrees of freedom

Results
rsp (CI)

Placebo I

Placebo II

No treatment (n = 18)

−0.16 (−0.39, 0.08)

Placebo (n=43)

0.13 (−0.08, 0.37)

No treatment (n=11)

0.08 (−0.11, 0.31)

Placebo (n=32)

0.01 (−0.15, 0.20)

Drug (n=30)

−0.11 (−0.26, 0.06)

Results (cont.)

Conclusions
The relationship between pain variability and relief is weak and inconsistent;
should not be used as a univariate predictor of relief in any group of a clinical
trial
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Sensitivity Analysis

Correlations without “the model”
rsp (CI)
Placebo I
Within-group
change score,
no pre covariate

Placebo II

No treatment (n =
18)

−0.33 (−0.73, 0.23)

Placebo (n=43)

0.16 (−0.23, 0.45)

No treatment
(n=11)

0.31 (−0.80, 0.79)

Placebo (n=32)

0.28 (−0.09, 0.52)

Drug (n=30)
No treatment (n =
18)

Placebo I

Within-group,
with pre covariate Placebo II

Placebo (n=43)

0 (−0.27, 0.40)
−0.30 (−0.61, 0.19)
0 (−0.37, 0.28)

No treatment
(n=11)

0.68 (−0.20, 0.91)

Placebo (n=32)

0.22 (−0.16, 0.52)

Drug (n=30)

−0.10 (−0.40, 0.42)

